FITIX
Price
$21.88
Change
+$0.14 (+0.64%)
Updated
Jul 3 closing price
Net Assets
1.51B
VIMAX
Price
$351.59
Change
+$2.07 (+0.59%)
Updated
Jul 3 closing price
Net Assets
185.28B
Interact to see
Advertisement

FITIX vs VIMAX

Header iconFITIX vs VIMAX Comparison
Open Charts FITIX vs VIMAXBanner chart's image
Fidelity Advisor Mid Cap II M
Price$21.88
Change+$0.14 (+0.64%)
VolumeN/A
Net Assets1.51B
Vanguard Mid Cap Index Admiral
Price$351.59
Change+$2.07 (+0.59%)
VolumeN/A
Net Assets185.28B
FITIX vs VIMAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FITIX vs. VIMAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FITIX is a StrongBuy and VIMAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMAX has more cash in the bank: 185B vs. FITIX (1.51B). VIMAX pays higher dividends than FITIX: VIMAX (1.52) vs FITIX (0.00). FITIX was incepted earlier than VIMAX: FITIX (21 years) vs VIMAX (24 years). FITIX (1.21) is less costly to investors than VIMAX (0.05). FITIX is a more actively managed with annual turnover of: 52.00 vs. VIMAX (16.00). FITIX has a lower initial minimum investment than VIMAX: FITIX (0) vs VIMAX (3000). VIMAX annual gain was more profitable for investors over the last year : 17.65 vs. FITIX (0.88). VIMAX return over 5 years is better than : 73.78 vs. FITIX (32.85).
FITIXVIMAXFITIX / VIMAX
Total Expense Ratio1.210.052,420%
Annual Report Gross Expense Ratio1.210.052,420%
Fund Existence21 years24 years-
Gain YTD-1.2197.630-16%
Front Load4%N/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.51B185B1%
Annual Yield % from dividends0.001.52-
Returns for 1 year0.8817.655%
Returns for 3 years22.9243.1353%
Returns for 5 years32.8573.7845%
Returns for 10 years12.78127.5510%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IBTN23.890.39
+1.66%
InsCorp, Inc.
PXGYF0.74N/A
N/A
Pax Global Technology Ltd
ZLDAF0.28N/A
N/A
Zelira Therapeutics Ltd.
SRTOY24.18N/A
N/A
Sartorius Stedim Biotech
VRLAF29.74N/A
N/A
VERALLIA, COURBEVOIE